Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.

Bakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang YT, Weber MA; ACCOMPLISH Trial investigators.

Lancet. 2010 Apr 3;375(9721):1173-81. doi: 10.1016/S0140-6736(09)62100-0. Epub 2010 Feb 18.

PMID:
20170948
2.

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators.

N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182.

3.

Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study.

Lindberg G, Lindblad U, Löw-Larsen B, Merlo J, Melander A, Råstam L.

Pharmacoepidemiol Drug Saf. 2002 Sep;11(6):493-7.

PMID:
12426934
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk